Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
Search for:
Insulin9623 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A20812 | 25716573 | J Diabetes Complications | Excess intake of fat and sugar potentiates epinephrine-induced hyperglycemia in male rats. | 2014 | Details |
| A20813 | 25716275 | Expert Rev Gastroenterol Hepatol | Management and diagnosis of fatty liver disease. | 2015 | Details |
| A20817 | 25714786 | Metab Syndr Relat Disord | A Perspective on Metabolic Syndrome and Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A20818 | 25714671 | Am J Physiol Endocrinol Metab | Liver protein profiles in insulin receptor-knockout mice reveal novel molecules involved in the diabetes pathophysiology. | 2015 | Details |
| A20827 | 25708949 | Naunyn Schmiedebergs Arch Pharmacol | Protective effect of boswellic acids versus pioglitazone in a rat model of diet-induced non-alcoholic fatty liver disease: influence on insulin resistance and energy expenditure. | 2015 | Details |
| A20832 | 25706109 | Curr Drug Targets | Discovery of Novel Anti-Diabetic Drugs by Targeting Lipid Metabolism. | 2015 | Details |
| A20833 | 25705637 | Ann Transl Med | Recent advances in the development of farnesoid X receptor agonists. | 2015 | Details |
| A20835 | 25703085 | J Hepatol | PPARα gene expression correlates with severity and histological treatment response in patients with non-alcoholic steatohepatitis. | 2015 | Details |
| A20840 | 25697178 | Br J Nutr | Dietary trans-10, cis-12-conjugated linoleic acid alters fatty acid metabolism and microbiota composition in mice. | 2015 | Details |
| A20841 | 25697114 | Med Hypotheses | Serum levels of toxic AGEs (TAGE) may be a promising novel biomarker in development and progression of NASH. | 2015 | Details |
| A20846 | 25690560 | Eur J Clin Invest | Low-normal thyroid function and the pathogenesis of common cardio-metabolic disorders. | 2015 | Details |
| A20847 | 25690422 | Nutrients | Low-normal thyroid function and novel cardiometabolic biomarkers. | 2015 | Details |
| A20851 | 25686742 | Dig Dis Sci | Prevalence of Insulin Resistance in Subjects with Nonalcoholic Fatty Liver Disease and Its Predictors in a Chinese Population. | 2015 | Details |
| A20862 | 25681381 | Clin Infect Dis | Nonalcoholic Steatohepatitis and Hepatic Fibrosis in HIV-1-Monoinfected Adults With Elevated Aminotransferase Levels on Antiretroviral Therapy. | 2015 | Details |
| A20868 | 25677815 | Digestion | Association between serum osteocalcin levels and non-alcoholic fatty liver disease in women. | 2015 | Details |
| A20870 | 25676019 | Front Med | Metformin and metabolic diseases: a focus on hepatic aspects. | 2015 | Details |
| A20875 | 25671801 | Horm Metab Res | Does metformin treatment influence bone formation in patients with nonalcoholic fatty liver disease? | 2015 | Details |
| A20876 | 25671200 | J Exerc Nutrition Biochem | Effect of aerobic exercise training on non-alcoholic fatty liver disease induced by a high fat diet in C57BL/6 mice. | 2014 | Details |
| A20877 | 25670619 | Arab J Gastroenterol | Effects of fenugreek, Nigella, and termis seeds in nonalcoholic fatty liver in obese diabetic albino rats. | 2015 | Details |
| A20879 | 25669174 | Clin Pharmacol Ther | Altered morphine glucuronide and bile acid disposition in patients with nonalcoholic steatohepatitis. | 2015 | Details |
| A20880 | 25668433 | PLoS Negl Trop Dis | Trypanosoma cruzi infection is a potent risk factor for non-alcoholic steatohepatitis enhancing local and systemic inflammation associated with strong oxidative stress and metabolic disorders. | 2015 | Details |
| A20885 | 25664838 | Nutr Diabetes | Determining the association between adipokine expression in multiple tissues and phenotypic features of non-alcoholic fatty liver disease in obesity. | 2015 | Details |
| A20890 | 25659874 | Atheroscler Suppl | The effect of ezetimibe on NAFLD. | 2015 | Details |
| A20895 | 25657751 | J Res Med Sci | The relationship between resistin and ghrelin levels with fibrosis in nonalcoholic fatty liver disease. | 2014 | Details |
| A20897 | 25655569 | J Cell Physiol | The SRE Motif in the Human PNPLA3 Promoter (-97 to -88 bp) Mediates Transactivational Effects of SREBP-1c. | 2015 | Details |
| A20902 | 25654291 | Zhonghua Gan Zang Bing Za Zhi | [Impact of JNK inhibitor XG-102 in a diet-induced rat model of non-alcoholic steatohepatitis]. | 2014 | Details |
| A20906 | 25651169 | Cell Metab | Turn up the heat: circulating serotonin tunes our internal heating system. | 2015 | Details |
| A20908 | 25649191 | Obes Res Clin Pract | Elevation of branched-chain amino acid levels in diabetes and NAFL and changes with antidiabetic drug treatment. | 2015 | Details |
| A20909 | 25648740 | Eur J Nutr | Self-reported eating speed in relation to non-alcoholic fatty liver disease in adults. | 2015 | Details |
| A20910 | 25648511 | Mar Drugs | Seaweed supplements normalise metabolic, cardiovascular and liver responses in high-carbohydrate, high-fat fed rats. | 2015 | Details |
| A20915 | 25646886 | J Hepatol | Hepatic STAMP2 alleviates high fat diet-induced hepatic steatosis and insulin resistance. | 2015 | Details |
| A20916 | 25646773 | PLoS One | Livers with constitutive mTORC1 activity resist steatosis independent of feedback suppression of Akt. | 2015 | Details |
| A20918 | 25646328 | Am J Clin Nutr | Isoleucine-to-methionine substitution at residue 148 variant of PNPLA3 gene and metabolic outcomes in gestational diabetes. | 2014 | Details |
| A20922 | 25643684 | Gac Med Mex | [Hepatic steatosis (HS) as a factor associated with the presence of metabolic risk in schoolchildren and obese adolescents]. | 2014 | Details |
| A20931 | 25633064 | Arch Dis Child | Paediatric non-alcoholic fatty liver disease: a practical overview for non-specialists. | 2015 | Details |
| A20935 | 25632188 | World J Gastroenterol | Factors associated with significant liver fibrosis assessed using transient elastography in general population. | 2015 | Details |
| A20942 | 25624996 | World J Hepatol | Adiponectin serum level in chronic hepatitis C infection and therapeutic profile. | 2015 | Details |
| A20953 | 25619540 | Curr Diabetes Rev | Is type 2 diabetes mellitus a predisposal cause for developing hepatocellular carcinoma? | 2015 | Details |
| A20957 | 25617860 | Atherosclerosis | A concise review of non-alcoholic fatty liver disease. | 2015 | Details |
| A20963 | 25617046 | Expert Rev Gastroenterol Hepatol | Effects of Mediterranean diet supplemented with silybin-vitamin E-phospholipid complex in overweight patients with non-alcoholic fatty liver disease. | 2015 | Details |
| A20967 | 25614040 | J Spinal Cord Med | Low testosterone and non-alcoholic fatty liver disease: Evidence for their independent association in men with chronic spinal cord injury. | 2016 | Details |
| A20973 | 25609431 | FASEB J | Protein kinase STK25 regulates hepatic lipid partitioning and progression of liver steatosis and NASH. | 2015 | Details |
| A20975 | 25607821 | Oncol Rep | Hepatic expression of the Sptlc3 subunit of serine palmitoyltransferase is associated with the development of hepatocellular carcinoma in a mouse model of nonalcoholic steatohepatitis. | 2015 | Details |
| A20981 | 25604802 | Expert Opin Investig Drugs | Early investigational drugs targeting PPAR-α for the treatment of metabolic disease. | 2015 | Details |
| A20982 | 25603556 | Biochim Biophys Acta | Palmitate activation by fatty acid transport protein 4 as a model system for hepatocellular apoptosis and steatosis. | 2015 | Details |
| A20986 | 25601465 | Curr Mol Med | Understanding nutritional interventions and physical exercise in non-alcoholic fatty liver disease. | 2015 | Details |
| A20992 | 25598791 | Hepat Mon | Are women with polycystic ovarian syndrome at a high risk of non-alcoholic Fatty liver disease; a meta-analysis. | 2014 | Details |
| A20996 | 25595882 | J Hepatol | Two non-psychoactive cannabinoids reduce intracellular lipid levels and inhibit hepatosteatosis. | 2015 | Details |
| A20997 | 25593466 | World J Gastroenterol | miRNA-103: molecular link between insulin resistance and nonalcoholic fatty liver disease. | 2015 | Details |
| A20998 | 25592661 | Clin Gastroenterol Hepatol | Association Between Endogenous Sex Hormones and Liver Fat in a Multiethnic Study of Atherosclerosis. | 2015 | Details |
| A21004 | 25583095 | Clin Biochem | Laboratory assessment of cardiometabolic risk in overweight and obese children. | 2015 | Details |
| A21011 | 25577467 | J Nutr Biochem | Saturated fat and cholesterol are critical to inducing murine metabolic syndrome with robust nonalcoholic steatohepatitis. | 2014 | Details |
| A21012 | 25577300 | Dig Liver Dis | Resveratrol improves insulin resistance, glucose and lipid metabolism in patients with non-alcoholic fatty liver disease: a randomized controlled trial. | 2014 | Details |
| A21014 | 25576095 | J Nutr Biochem | Maternal taurine supplementation attenuates maternal fructose-induced metabolic and inflammatory dysregulation and partially reverses adverse metabolic programming in offspring. | 2014 | Details |
| A21017 | 25575111 | Can J Gastroenterol Hepatol | Biomarkers in nonalcoholic fatty liver disease. | 2014 | Details |
| A21018 | 25574593 | Diabetes Technol Ther | Relationship between β-cell function, metabolic control, and microvascular complications in type 2 diabetes mellitus. | 2015 | Details |
| A21021 | 25573175 | Am J Physiol Gastrointest Liver Physiol | Chronic NOS inhibition accelerates NAFLD progression in an obese rat model. | 2015 | Details |
| A21027 | 25566193 | Front Endocrinol (Lausanne) | O-GlcNAc: A Bittersweet Switch in Liver. | 2014 | Details |
| A21028 | 25566190 | Front Endocrinol (Lausanne) | Evolution of hepatic steatosis to fibrosis and adenoma formation in liver-specific growth hormone receptor knockout mice. | 2014 | Details |
| A21036 | 25563143 | Eur J Gastroenterol Hepatol | Nonalcoholic fatty liver disease as a potential risk factor of cardiovascular disease. | 2015 | Details |
| A21037 | 25562616 | Endocrinology | Prevention and reversal of lipotoxicity-induced hepatic insulin resistance and steatohepatitis in mice by an antioxidant carotenoid, β-cryptoxanthin. | 2015 | Details |
| A21038 | 25562318 | J Clin Invest | Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis. | 2014 | Details |
| A21039 | 25562147 | Cell Physiol Biochem | Aberrant hepatic microRNA expression in nonalcoholic fatty liver disease. | 2014 | Details |
| A21049 | 25554608 | Endokrynol Pol | Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism. | 2014 | Details |
| A21050 | 25553983 | Eur J Intern Med | Prevalence of steatosis and insulin resistance in patients with chronic hepatitis B compared with chronic hepatitis C and non-alcoholic fatty liver disease. | 2014 | Details |
| A21054 | 25550952 | Int J Clin Exp Med | Assessment of hepatic steatosis on contrast enhanced computed tomography in patients with colorectal cancer. | 2014 | Details |
| A21059 | 28596988 | J Diabetes Obes | NAFLD Susceptibility Genes and their Association with Type 2 Diabetes and Obesity in a New Mexico Population. | 2015 | Details |
| A21060 | 28356818 | J Med Biochem | Epidemiology and Natural History of NAFLD. | 2014 | Details |
| A21061 | 28356817 | J Med Biochem | Pediatric Non-Alcoholic Fatty Liver Disease. | 2014 | Details |
| A21063 | 27508191 | J Hepatocell Carcinoma | A clinical perspective of the link between metabolic syndrome and hepatocellular carcinoma. | 2015 | Details |
| A21064 | 27453880 | J Diabetes Metab Disord | The effects of onion consumption on treatment of metabolic, histologic, and inflammatory features of nonalcoholic fatty liver disease. | 2016 | Details |
| A21065 | 27417789 | Healthcare (Basel) | Fatty Liver and Fatty Heart-Where do They Stand in the AMIS Syndrome? | 2015 | Details |
| A21066 | 27214983 | Eksp Klin Gastroenterol | [INSULIN-LIKE GROWTH FACTOR-1: THE INFLUENCE ON THE LIVER FUNCTION AND RELATIONSHIPS WITH RESISTIN IN PATIENTS WITH NONALCOHOLIC FATTY LIVER DISEASE AND ITS COMBINATION WITH TYPE 2 DIABETES MELLITUS]. | 2015 | Details |
| A21069 | 27188459 | Nat Rev Dis Primers | Nonalcoholic fatty liver disease. | 2015 | Details |
| A21076 | 25548491 | World J Gastroenterol | Lean-non-alcoholic fatty liver disease increases risk for metabolic disorders in a normal weight Chinese population. | 2014 | Details |
| A21077 | 25548489 | World J Gastroenterol | MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease. | 2014 | Details |
| A21078 | 25548482 | World J Gastroenterol | Elevated free cholesterol in a p62 overexpression model of non-alcoholic steatohepatitis. | 2014 | Details |
| A21079 | 25548472 | World J Gastroenterol | Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective. | 2014 | Details |
| A21083 | 25544875 | World J Hepatol | Involvement of the TAGE-RAGE system in non-alcoholic steatohepatitis: Novel treatment strategies. | 2014 | Details |
| A21085 | 25544409 | Rev Esp Enferm Dig | Insulin resistance and metabolic syndrome are related to non-alcoholic fatty liver disease, but not visceral adiposity index, in severely obese patients. | 2014 | Details |
| A21087 | 25543522 | Clin Res Hepatol Gastroenterol | Nonalcoholic fatty liver disease (NAFLD) without insulin resistance: Is it different? | 2014 | Details |
| A21089 | 25542756 | Eur J Pharmacol | Ameliorative effect of nicorandil on high fat diet induced non-alcoholic fatty liver disease in rats. | 2014 | Details |
| A21091 | 25541279 | Prostaglandins Leukot Essent Fatty Acids | Ameliorative potential of omega 3 fatty acids and HMG-CoA reductase inhibitors on experimentally-induced non-alcoholic steatohepatitis. | 2014 | Details |
| A21095 | 25539480 | Med Sci Sports Exerc | Effect of Training Intensity on Nonalcoholic Fatty Liver Disease. | 2015 | Details |
| A21098 | 25536650 | Ann Hepatol | Lifestyle changes associated with a new antioxidant formulation in non-alcoholic fatty liver disease: a case series. | 2015 | Details |
| A21103 | 25534988 | Biochem Pharmacol | The liver-selective NO donor, V-PYRRO/NO, protects against liver steatosis and improves postprandial glucose tolerance in mice fed high fat diet. | 2014 | Details |
| A21104 | 25534442 | Life Sci | Role of physical exercise on hepatic insulin, glucocorticoid and inflammatory signaling pathways in an animal model of non-alcoholic steatohepatitis. | 2014 | Details |
| A21105 | 25534430 | Amino Acids | Branched chain amino acid metabolism profiles in progressive human nonalcoholic fatty liver disease. | 2014 | Details |
| A21108 | 25533429 | Eur J Gastroenterol Hepatol | Effects of ursodeoxycholic acid therapy on carotid intima media thickness, apolipoprotein A1, apolipoprotein B, and apolipoprotein B/A1 ratio in nonalcoholic steatohepatitis. | 2015 | Details |
| A21111 | 25533006 | Nutrients | Simple sugar intake and hepatocellular carcinoma: epidemiological and mechanistic insight. | 2014 | Details |
| A21117 | 25531383 | Zhonghua Gan Zang Bing Za Zhi | [Liraglutide protects against nonalcoholic fatty liver disease in ApoE knockout mice with high-fat diet and silenced Acrp30 by increasing AMPK]. | 2014 | Details |
| A21118 | 25530013 | Nutr Res | Blood redox status is associated with the likelihood of nonalcoholic fatty liver disease irrespectively of diet's total antioxidant capacity. | 2014 | Details |
| A21125 | 25527748 | Am J Clin Nutr | Palmitoleic acid is elevated in fatty liver disease and reflects hepatic lipogenesis. | 2014 | Details |
| A21128 | 25526027 | Oncotarget | Wnt signaling, de novo lipogenesis, adipogenesis and ectopic fat. | 2014 | Details |
| A21133 | 25524401 | Hepatology | The impact of phlebotomy in nonalcoholic fatty liver disease: A prospective, randomized, controlled trial. | 2015 | Details |
| A21143 | 25516477 | Metabolism | The role of fibroblast growth factor 21 in the pathogenesis of non-alcoholic fatty liver disease and implications for therapy. | 2014 | Details |
| A21144 | 25516385 | J Gastroenterol | The association between retinal microvascular changes, metabolic risk factors, and liver histology in pediatric patients with non-alcoholic fatty liver disease (NAFLD). | 2014 | Details |
| A21146 | 25514916 | Rev Recent Clin Trials | Non alcoholic fatty liver: epidemiology and natural history. | 2014 | Details |
| A21148 | 25514914 | Rev Recent Clin Trials | Phytotherapy and NAFLD--from goals and challenges to clinical practice. | 2014 | Details |
| A21150 | 25514912 | Rev Recent Clin Trials | Use of liver breath tests to assess severity of nonalcoholic fatty liver disease. | 2014 | Details |